GLP-1 Impact: Formulation Shifts Drive Demand for Nutrient-Dense, Smaller Portions
The rise of GLP-1 users is fundamentally reshaping product development, demanding smaller, nutrient-dense formats that integrate clean label, protein, and plant-based solutions. Brands must now balance enhanced nutrition with taste, texture, and cost for commercial viability.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Chicago, United States — 14 July 2026
Foodology by Univar Solutions, exhibiting at IFT FIRST 2026, has highlighted a critical confluence of formulation priorities driven by the increasing use of GLP-1 medications. The company posits that GLP-1-aligned product development, clean label reformulation, protein fortification, and plant-based alternatives are not isolated innovation tracks but interconnected demands on manufacturers. Charles Purcell, Technical Leader at Foodology by Univar Solutions, noted that GLP-1 adoption is compelling a re-evaluation of food industry formulation, shifting focus towards smaller, more nutrient-dense portions.
This market dynamic places significant pressure on brands to deliver enhanced nutritional value within reduced serving sizes. The core challenge involves optimising satiety, nutrient density, and functional benefits while meticulously managing taste, texture, and digestibility. Purcell highlighted that for GLP-1 users, satiety is already augmented by the medication, making smaller portion sizes a necessity. This accentuates the need for 'positive nutrient value' in functional ingredients to compensate for reduced overall consumption volumes. Foodology classifies GLP-1 eating patterns as one of seven key trends for 2026, alongside digestive health, clean label, and functional foods, all impacting product development.
Foodology’s prototypes at IFT FIRST, such as the LeanLift Mediterranean Protein Pocket and HerbHarvest Pea Protein Cracker, demonstrate how familiar consumer formats are being adapted. These examples blend high protein content, plant-based elements, and clean label attributes, explicitly targeting GLP-1 user preferences. The LeanLift Mediterranean Protein Pocket, for instance, incorporates plant-boosted meat, protein fortification, and cost optimisation within a 'GLP-1 friendly' framework. Crucially, maintaining sensory quality – taste and texture – remains the primary hurdle for commercial success, according to Purcell, as this drives repeat purchases despite increased nutritional complexity and cost targets.
The integration of ingredients like pea protein, soluble corn fibre, and collagen into everyday items, ranging from crackers to fortified gelatin shots and functional sodas, signals a move for functional nutrition into mainstream consumption. However, the commercial success of these innovations will depend on brand owners' ability to strategically manage ingredient costs, navigate complex labelling requirements, ensure sensory appeal, and secure consumer acceptance within often-saturated categories. Larger CPG firms are prioritising ingredient alternatives for cleaner labels, while mid-sized manufacturers seek technical validation for performance. This reflects a broader industry recognition that innovation across these once-distinct categories must now be integrated to remain competitive.
What this means for United Kingdom
UK supplement manufacturers and brand owners must immediately re-assess product portfolios and R&D pipelines. The GLP-1 trend, while originating in North America, will significantly influence consumer demand for nutrient-dense, high-protein, and fibre-rich products in smaller, convenient formats across the UK market within 12-18 months. Reformulation investments will be critical to integrate clean label criteria with enhanced protein (e.g., 20g+ per serving) and fibre (e.g., 5g+ per serving) content. Procurement teams should anticipate increased demand and potential price volatility for specific functional ingredients, particularly dairy and plant-based proteins, and soluble fibres, necessitating proactive supply chain agreements. Compliance with UK-specific nutrition labelling regulations for 'high protein' or 'source of fibre' claims will require meticulous product development and ingredient sourcing due to these concentrated formulations.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.